AFIRM Act

The AFIRM Act, also known as Bill 114 s 2368, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to establish the Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health (NIH). This agency would be responsible for accelerating biomedical innovation and research in order to address urgent health challenges.

The AFIRM Act aims to provide ARPA-H with the necessary resources and authority to fund high-risk, high-reward research projects that have the potential to significantly impact public health. The bill also emphasizes the importance of collaboration between ARPA-H and other federal agencies, as well as the private sector, in order to maximize the impact of research investments.

Additionally, the AFIRM Act includes provisions to ensure transparency and accountability in the use of funds allocated to ARPA-H. This includes requirements for regular reporting on the progress of funded projects, as well as mechanisms for evaluating the effectiveness of ARPA-H's research initiatives. Overall, the AFIRM Act seeks to promote innovation and collaboration in biomedical research in order to address pressing health challenges and improve public health outcomes. It represents a bipartisan effort to support cutting-edge research and development in the healthcare sector.